Federal Register Notice: FDA announces a public workshop 2/12-13 convened by the Institute of Medicine: “Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks in Drug Regulatory Decision-Making.” The workshop will explore potential approaches to addressing and communicating uncertainty and to identify key considerations on developing, evaluating, and incorporating potential approaches for addressing uncertainty into the assessment of benefits and risks in the human drug review process. The workshop will be held 2/12, from 8:30 a.m. to 4:30 p.m. and 2/13, from 8:30 a.m. to 3:30 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, Rm. 1503A, Silver Spring, MD, Contact Sara Eggers, (301) 796-4904. To view this notice, click here.